Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Incidence and survival of head and neck cancer in the Faroe Islands

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Low prevalence of retinopathy among Greenland Inuit

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. No association between early maternal HbA1c and offspring birthweight among women without pre-existing diabetes in Greenland

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Diabetes in Greenland - how to deliver diabetes care in a country with a geographically dispersed population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Nasopharyngeal malignancies in Denmark diagnosed from 1980 to 2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Systematic review on the current knowledge and use of Single-cell RNA Sequencing in Head and Neck Cancer

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Impact of human papillomavirus in sinonasal cancer-a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Background: The Faroese people constitute a geographically isolated population, and research on cancer in this population is sparse. Thus, this study aimed to calculate the age-standardised incidence rate (ASIR) and 5-year survival rates in head and neck cancers (HNC) in the Faroese population from 1985 to 2017.Materials and methods: All patients registered with HNC in the Faroese Cancer Registry (FCR) from 1985 to 2017 were included. The ASIR per 100,000 (World Standard Population) and 5-year survival rates were calculated. We also calculated the distribution of tobacco, alcohol consumption, cancer stages and various timelines. Results: 202 patients were included in the study (62% men). The ASIR for all HNC was 10.0/100,000 persons-years and was higher among men than women. Women's survival rate was significantly higher than men's (p = 0.026). The results imply that oropharyngeal cancer (OPC) had the best survival rate and was diagnosed at a significantly earlier stage.Conclusion: This retrospective nation-wide study showed that ASIRs and 5-year survival rates for Faroese HNC patients in general resembled the ones reported for Danish HNC patients. Timelines for Faroese HNC patients were shorter compared with Greenlandic HNC patients, but longer compared with the Danish fast track programme limits.

OriginalsprogEngelsk
Artikelnummer1894697
TidsskriftInternational Journal of Circumpolar Health
Vol/bind80
Udgave nummer1
Sider (fra-til)1894697
ISSN1239-9736
DOI
StatusUdgivet - 1 jan. 2021

ID: 67843833